UPMC HANOVER — History
CCN 390233 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$201M
Latest Revenue (FY2022)
+8.6%
Revenue CAGR (3yr)
18.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $170M | $177M | $201M | +13.6% | +8.6% |
| Operating Expenses | $133M | $149M | $164M | +10.6% | +11.0% |
| Operating Margin | 21.6% | 16.0% | 18.2% | +13.4% | -8.2% |
| Net Income | $37M | $28M | $36M | +28.8% | -0.3% |
| Licensed Beds | 81 | 81 | 73 | -9.9% | -5.1% |
| Total Patient Days | 22,098 | 24,469 | 23,226 | -5.1% | +2.5% |
| Medicare Day % | 38% | 36% | 39% | +9.1% | +1.4% |
| Medicaid Day % | 3% | 3% | 3% | -2.9% | -0.3% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +18.0% ($170M → $201M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+8.6%
This Hospital
+7.6%
State Avg
Latest Margin
18.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $216M | 16.5% |
| FY2024 (proj) | $231M | 14.7% |
| FY2025 (proj) | $247M | 13.0% |